Study of possibility of cell recognition in brain tumors

Abstract

The brain has an exceptionally high requirement for energy metabolism, with glucose serving as the exclusive energy source. Cancers, including glioblastoma, have a high glucose uptake and rely on aerobic glycolysis for energy metabolism. The alternation of high-efficiency oxidative phosphorylation to a low-efficiency aerobic glycolysis pathway (Warburg effect) provides macromolecules for biosynthesis and proliferation. Current research indicates that the specific metabolism in the tumor tissue and normal brain tissue in the glioma allows the use of 5-aminolevulinic acid (5 ALA)-induced protoporphyrin IX (PpIX) and methylene blue (MB) to monitor and correct the development of the tumor. The focus is on the detection of the differences between tumor cells and tumor-associated macrophages/microglia using spectroscopic and microscopic methods, based on the fluorescent signals and the difference in the drug accumulation of photosensitizers (PSs). Since 5 ALA has long been used effectively in the clinic for fluorescent surgical navigation, it was employed as an agent to identify the localization of tumor tissue and study its composition, particularly tumor and immune cells (macrophages), which have also been shown to actively accumulate PpIX. However, since PpIX is photodynamically active, it can be considered effective as the main target of tumor tissue for further successful photodynamic therapy. MB was employed to visualize resident microglia, which is important for their activation/deactivation to prevent the reprogramming of the immune cells by the tumor. Thus, using two drugs, it is possible to prevent crosstalk between tumor cells and the immune cells of different geneses.

Graphical abstract

Keywords

fluorescent diagnostics / spectroscopic method / video fluorescent method / photosensitizer (PS) / brain / microglia / macrophages / 5-aminolevulinic acid (5 ALA) / methylene blue (MB)

References

[1] Bahadur S, Sahu A K, Baghel P, Saha S. Current promising treatment strategy for glioblastoma multiform: a review. Oncology Reviews, 2019, 13(2): 417

[2] McGranahan T, Therkelsen K E, Ahmad S, Nagpal S. Current state of immunotherapy for treatment of glioblastoma. Current Treatment Options in Oncology, 2019, 20(3): 24

[3] Wolf S A, Boddeke H W G M, Kettenmann H. Microglia in physiology and disease. Annual Review of Physiology, 2017, 79(1): 619–643

[4] Norris G T, Kipnis J. Immune cells and CNS physiology: microglia and beyond. Journal of Experimental Medicine, 2019, 216(1): 60–70

[5] Sampson J H, Gunn M D, Fecci P E, Ashley D M. Brain immunology and immunotherapy in brain tumours. Nature Reviews. Cancer, 2020, 20(1): 12–25

[6] Salter M W, Stevens B. Microglia emerge as central players in brain disease. Nature Medicine, 2017, 23(9): 1018–1027

[7] Quail D F, Joyce J A. The microenvironmental landscape of brain tumors. Cancer Cell, 2017, 31(3): 326–341

[8] Korbelik M, Krosl G. Photofrin accumulation in malignant and host cell populations of various tumours. British Journal of Cancer, 1996, 73(4): 506–513

[9] Oz M, Lorke D E, Hasan M, Petroianu G A. Cellular and molecular actions of Methylene Blue in the nervous system. Medicinal Research Reviews, 2011, 31(1): 93–117

[10] Tucker D, Lu Y, Zhang Q. From mitochondrial function to neuroprotection–an emerging role for methylene blue. Molecular Neurobiology, 2018, 55(6): 5137–5153

[11] Stepp H, Stummer W. 5-ALA in the management of malignant glioma. Lasers in Surgery and Medicine, 2018, 50(5): 399–419

[12] Filonenko E V, Kaprin A D, Raszhivina A A, Urlova A N, Nechipai A M. Fluorescence diagnostics of colon malignant and premalignant lesions using 5-aminolevulinic acid. International Journal of Photoenergy, 2014, 2014: 378673

[13] Spijker S. Dissection of Rodent Brain Regions. In: Li K, ed. Neuroproteomics, vol 57. 2011. Totowa, NJ: Humana Press, 13–26

[14] Peters S R. A Practical Guide to Frozen Section Technique. New York: Springer, 2010

[15] Chekhonin V P, Baklaushev V P, Yusubalieva G M, Pavlov K A, Ukhova O V, Gurina O I. Modeling and immunohistochemical analysis of C6 glioma in vivo. Bulletin of Experimental Biology and Medicine, 2007, 143(4): 501–509

Acknowledgments

The reported study was funded by Russian Foundation for Basic Research according to the research project No. 18-29-01062.

RIGHTS & PERMISSIONS

2020 Higher Education Press